Sean Svendsen's profile

Myriad Neuroscience’s GeneSight® test kit

Myriad GeneSight® Psychotropic Patient Collection Kit
Myriad Neuroscience provides a clinical test kit designed to assist physicians (in-office) with the proper prescription of medications for treating diagnosed mental health conditions. In response to COVID-19 and market shifts towards tele-medicine and remote exams, Myriad Neuroscience wanted to update its clinical based test kit to offer a new self-administered home test kit design that could be mailed directly to patients.
Design Challenge:
Create a patient-focused sample collection kit which provides clear easy to understand instructions for use (IFU) that facilitated:
- Proper collection of patient medical history and insurance information
- Proper collection of DNA test samples
- Proper and prompt return to a lab for analysis
- Increased compliance

Leverage existing consumables such as swabs, collection tubes and insurance forms Align visuals and messaging with established GeneSight® brand identity, website, and other digital and print collateral. Create a better patient experience to instill greater confidence in the test outcomes. Deliver production ready art within 4 weeks

  
 Process:
A heuristic review of the existing IFU design was done using established human factors standards and regulatory guidance documents.
- AAMI HE75: Human Factors Engineering for Medical
- AAMI TIR49: Design of training and instructional materials for medical devices used in non-clinical environments
- Verbiage and visual guidance for optimal usability
- Font size and color contrast for optimal readability 

A small usability study and task analysis was conducted with the test kit components to identify key challenges/opportunities with collecting patient data, biologic samples and then shipping the collection kit back to the lab. We discovered several steps that lacked a clear hierarchical structure, causing task confusion. Additionally, some instructions were separated from the task, causing participants to skip steps. We also wanted to understand how to better organize kit components so they would be easier for users to handle and ship.

From these insights, a series of concepts was done exploring opportunities to improve usability while enhancing the overall user experience. Various packaging options and materials were also considered to optimize manufacturing cost.

Following alignment on a final graphic design with our client, final production ready art was created and coordinated with the print vendor for production.
Product Solution:
The final design solution is a tri-fold binder that organizes the test kit components into an easy to follow 3-step process. Step 1 instructs how to collect patient data. Step 2 instructs how to properly collect the DNA samples and Step 3 instructs patients how to return ship the samples in the provided envelope.

The tri-fold solution created a visual hierarchy of steps to better guide users through the process. The folder also organizes the kit components and directly aligns them with the IFU in each step for better usability. Color coding the steps and kit components further strengthens these relationships.

The graphics follow established Myriad brand guidelines and feature messaging to help explain what the test is for and the benefit of following through with testing. A call to action is prominently displayed on the inside center spread to prompt patients to return the test quickly for improved outcomes. Telephone help guidance was also added to further aid patients if they had questions during testing.

The test kit folder is printed with variety of varnishes on a heavy weight paper stock to subtly improve the usability. A spot gloss varnish was used to create a high-quality visual appearance and highlight key information. A soft-touch matt varnish was used in other areas to create a warm, approachable feel when handled. Thoughtful consideration of color, tone of voice and use of white space help create a calming influence to further reduce anxieties. All these elements work together to help increase the perception of quality and provide more confidence in the outcomes of the test.
Impact:
- Improved the patient experience by providing simple, clear instructions
- Helped deliver a 73% return rate (the industry benchmark is 70%)
- Improved “time to return” by patients 35% over the clinical test kit.
- Reduced exceptions from incomplete/incorrect information by 10% over the clinic kit.
- Enabled Myriad to launch a fully functional in-home collection kit within 4 weeks
Myriad Neuroscience’s GeneSight® test kit
Published:

Myriad Neuroscience’s GeneSight® test kit

Published: